CIM
UTHR icon

Chiron Investment Management’s United Therapeutics UTHR Stock Holding History

Chiron Investment Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$732K Buy
2,074
+984
+90% +$362K 0.24% 68
2024
Q3 		$391K Buy
+1,090
New +$368K 0.14% 70
2023
Q2 		– Sell
-3,467
Closed -$776K – 191
2023
Q1 		$776K Buy
+3,467
New +$855K 0.14% 65
2022
Q4 		– Sell
-540
Closed -$113K – 175
2022
Q3 		$113K Buy
+540
New +$121K 0.02% 115

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Chiron Investment Management's UTHR Position: Q4 2024 in Review

Chiron Investment Management increased its United Therapeutics (UTHR) stake by 90% in Q4 2024, buying an estimated $362K and bringing the position to 2,074 shares worth $732K. The position accounts for 0.24% of the portfolio, ranked #68.

Chiron Investment Management first reported a position in UTHR in Q3 2022 and has held it in 4 quarters since. The position peaked at $776K in Q1 2023. 673 funds tracked by Wall St. Rank hold UTHR as of Q4 2024.

  • Chiron Investment Management held 2,074 shares of United Therapeutics worth $732K as of Q4 2024.
  • Chiron Investment Management bought 984 United Therapeutics shares in Q4 2024, an estimated $362K.
  • United Therapeutics made up 0.24% of Chiron Investment Management's portfolio in Q4 2024, its #68 holding.
  • Chiron Investment Management first reported a position in United Therapeutics in Q3 2022 and has held it in 4 quarters since.
  • Chiron Investment Management's United Therapeutics position peaked at $776K in Q1 2023.
  • 673 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2024.

Based on Chiron Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.